Etaracizumab

Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer.
Read more
€0.00 (tax incl.)
Reference:
HY-P99291
Product Details
HY-P99291

Data sheet

Size
Multiple sizes
Reactivity
Integrin
Application
Cancer-programmed cell death
CAS
892553-42-3

Menu

Settings